Published in Law and Health Weekly, August 28th, 2004
Earnings were $18.6 million, or $.62 per diluted share, an increase of 12% from $16.6 million or $.56 for the second quarter of 2003. The dollar weakened relative to the Euro, but strengthened relative to the Real in the second quarter of 2004. Overall changes in currencies had a 3% positive impact on sales. International sales were $78.4 million and domestic sales were $32.1 million.
Sales of IMMULITE products continued to be very strong, growing 18% over the second quarter of 2003. IMMULITE product line...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.